Giant foreign body granuloma after endoscopic management of vesicoureteric reflux: a case report
Abstract Background Deflux®, a dextranomer/hyaluronic acid copolymer, is extensively used as an endoscopic bulking agent for management of vesicoureteric reflux (VUR). The complications following Deflux® treatment as described in the literature are clinically insignificant transient obstruction and...
Saved in:
Main Authors: | Saket Davera (Author), Anjan Dhua (Author), Shipra Agarwal (Author), Mohamed Sulaiman (Author) |
---|---|
Format: | Book |
Published: |
SpringerOpen,
2022-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Endoscopic treatment of vesicoureteral reflux in pediatric patients
by: Jong Wook Kim, et al.
Published: (2013) -
Endoscopic Management of Vesicoureteral Reflux in Duplex Renal Collecting Systems
by: Hasan Çayırlı, et al.
Published: (2022) -
Deflux® Endoscopic Treatment of Vesicoureteral Reflux (VUR) in Japan
by: The Japanese Deflux Injection Therapy Study Group
Published: (2022) -
Endoscopic Management of Complicated Highgrade Vesicoureteral Reflux in the First Year of Life
by: Ali Tekin, et al.
Published: (2021) -
Endoscopic treatment of vesicoureteral reflux with dextranomer/ hyaluronic acid-our experience
by: Prasad Mylarappa, et al.
Published: (2013)